The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 15, 2024
Filed:
Feb. 11, 2021
Applicant:
Immunitybio, Inc., San Diego, CA (US);
Inventor:
Hing C. Wong, Miramar, FL (US);
Assignee:
ImmunityBio, Inc., San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); A61K 35/17 (2015.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); C07K 14/435 (2006.01); C07K 14/705 (2006.01); C07K 16/28 (2006.01); C07K 16/36 (2006.01); C12N 5/0783 (2010.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/17 (2013.01); A61K 38/17 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); C07K 14/435 (2013.01); C07K 14/70596 (2013.01); C07K 16/2896 (2013.01); C07K 16/36 (2013.01); C12N 5/0637 (2013.01); C12N 5/0646 (2013.01); A61K 38/00 (2013.01); C07K 2319/01 (2013.01);
Abstract
Provided herein are methods of treating an aging-related disease or inflammatory disease in a subject that include (i) a therapeutically effective amount of an NK cell activating agent and/or an NK cell and/or monoclonal antibody; and (ii) a therapeutically effective amount of a Treg cell activating agent and/or a Treg cell and/or a monoclonal antibody and/or AGE inhibitor.